Intervet to divest part of feed additives business

10-Jun-2005

Akzo Nobel's animal healthcare business, Intervet, has agreed to divest some of its feed additives activities to Bulgarian company Biovet®. Both parties have agreed not to disclose financial details. Scheduled to be finalized on July 31, the agreement-which is subject to various corporate and governmental approvals-concerns the sale of Intervet's Sacox®, Salocin®, Flavomycin®, Gainpro®, Hostazym® and Stenorol® products.

"These activities no longer fit in with our core business operations and have become distanced from Intervet's portfolio from a strategic perspective," explained Akzo Nobel Board Member Toon Wilderbeek.

Other news from the department business & finance

Most read news

More news from our other portals

Discover the latest developments in battery technology!